The years of research the biopharmaceutical industry has invested in vaccine technology brings a range of benefits.
Life-saving vaccines for children and adults. 16 diseases are now preventable in the U.S. due to the development and availability of childhood vaccines and the introduction of a new shingles vaccines in 2017 has reduced the risk of shingles among older adults by 90%.
The ability to develop vaccines quickly and without relying on other countries makes America more secure.
The U.S was able to mobilize quickly to respond to the COVID-19 pandemic with a safe and effective vaccine in record time, savings millions from severe illness and death, and well over billions in avoidable health care costs.
Conditions like flu, pneumococcal disease, shingles and whopping cough, cost $27 billion in direct and indirect costs each year among adults over the age of 50.